The Specialist GP

Episode overviewWhat does it mean to be a Specialist GP — and why does it matter? In this episode, I’m joined by Dr Samantha Murton, Fellow of the Royal New Zealand College of General Practitioners (FRNZCGP). Together, we unpack what Fellowship really represents, why the title Specialist GP is so important, and how it sets us apart from general registrants or other health professionals. We talk about the training pathway, the value of the title, and how recognition translates into patient trust and safer care. Sam also explores the international perspective — why family physicians in the UK are paid on par with hospital specialists — and asks why New Zealand still lags behind. This conversation is a call to action: for GPs to proudly use their specialist title, for patients to understand its importance, and for all of us to advocate for recognition and pay parity in primary care. In this episode we coverWhat FRNZCGP means and why it matters Why the title “Specialist GP” makes a difference The importance of distinguishing Specialist GPs from other health professionals The training pathway and what it represents How recognition impacts patient care and trust International comparisons: the UK vs New Zealand Why advocacy is crucial for the future of General Practice What we can each do to support the cause Email [email protected] Here:Apple: https://podcasts.apple.com/nz/podcast/specialist-gp-why-recognition-matters-w-dr-samantha-murton/id1845748299?i=1000743708878Spotify: https://open.spotify.com/episode/1955idYIvAmXOyO9tuSMC2?si=QqgAmS_VSjGeGP_LedYnrQ

Dr. Louise Kuegler discusses the rising prevalence of oral tobacco and nicotine products, particularly among youth in New Zealand, with Dr. Jude Ball. They explore the differences between oral tobacco and nicotine products, their usage patterns, safety concerns, and the implications for public health. The conversation also touches on the role of these products in smoking cessation, regulatory challenges, and the need for further research in this area. In this episode we cover: Who is using oral nicotine products Safety and harms The role of oral nicotine in smoking cessation A case discussion Policy, advocacy, and guidance Looking forward Practical clinical pearls: Know what’s out there – pouches and lozenges are on the rise. Ask routinely – patients may use them alongside smoking or vaping. Safer ≠ safe – risks include nicotine dependence, oral disease, and cardiovascular harm. Evidence is limited – they don’t outperform proven NRT. Advocate – clinicians and parents should push back against normalisation of nicotine and call for strong regulation. Guest bio: Dr Jude Ball is a senior research fellow affiliated to the ASPIRE Aotearoa tobacco control research centre University of Otago, HePPRU, and the Adolescent Health Research Group (the team behind the Youth 2000 survey series). She joined the Department in November 2014 with a background in critical psychology, health promotion and applied research. She completed a PhD in 2019 exploring the drivers of long-term trends in adolescent risk behaviour, in particular smoking, cannabis use, binge drinking and sexual behaviour. Her research focuses on the impact of the changing social context on youth trends, and the inter-relationships between smoking and other risk behaviours in young people. Alcohol and drug harm and mental health promotion are also areas of research interest. Resources: https://www.phcc.org.nz/briefing/oral-tobacco-and-nicotine-products-quitting-aid-or-teen-addiction-risk

Episode Overview Suicide continues to be a major public health issue in Aotearoa New Zealand, touching every clinician working in primary care. General Practice is often the first, and sometimes only, point of contact before a suicide attempt — meaning GPs are uniquely placed to identify risk, provide support, and intervene early. In this episode of The Specialist GP, host Dr Louise Kuegler speaks with Dr Cheryl Buhay about the latest suicide data, key risk and protective factors, and effective management strategies. Together, they discuss how primary care teams can safely assess and manage suicide risk, when to escalate concerns, and how to look after themselves and colleagues affected by suicide. The conversation also explores the importance of clinician wellbeing, collaboration with specialist services, and building confidence in these difficult but crucial consultations. Key Discussion Points Current suicide data and inequities across age, gender, and ethnicity The most common risk factors and protective factors in suicide prevention How to conduct a safe, empathic, and thorough risk assessment When and how to involve specialist mental health services Support options for clinicians following patient suicide or distressing events Practical Clinical Pearls 1. Risk assessment runs parallel to diagnosis – consider both static and dynamic risk factors across social, mental, and physical domains. 2. Maintain a high index of suspicion – approach with empathy, curiosity, and non-judgement. 3. Don’t overlook broader risks – such as poor self-care, child safety, or physical health deterioration. 4. Watch for paradoxical calm – a patient who suddenly appears serene after deep distress may be at increased risk. 5. Use the team – involve nursing, community, and peer supports early. 6. Seek help when unsure – contact local mental health triage or crisis services for immediate consultation. Clinician Wellbeing Caring for someone at risk of suicide can be emotionally demanding. GPs are encouraged to access support through: EAP programmes (RNZCGP, MAS, MPS) Skylight Trust – 0800 299 100 | www.skylight.org.nz Aoake te Rā – free counselling for people bereaved by suicide | 0800 000 053 | www.aoaketera.org.nz After a Suicide NZ – www.afterasuicide.nz Email: [email protected]: https://www.thespecialistgp.co.nz/

Dr Louise Kuegler and Professor Ian Reid explore osteopenia—what it means, why it matters, and how it fits into fracture prevention. Drawing on the latest evidence, including Prof Ian Reid’s and Prof Mark Bolland's work, we discuss diagnosis, lifestyle strategies, treatment thresholds, and patient-centred approaches to protect bone health and prevent future fractures. An update for Zolendronate use is also discussed especially in the context of osteopenia.In this episode we cover:Definition of osteopenia and its prevalenceRisk factors and the role of exercise in bone healthAssessing fracture riskManagement strategies for osteopeniaThe importance and role of Menopause Hormone TherapyRecent advances in Zolendronate's role in Osteopenia and OsteoporosisAddressing osteopenia in menPractical clinical pearls:Aim for a BMI >20 to protect long-term bone health. Educate adolescents and young adult women that being underweight increases lifetime fracture risk.Screen by fracture risk, not osteoporosis alone. Start with a risk calculator such as FRAX or Garvan; use DEXA only to refine risk when the calculated risk is moderate or uncertain.Zoledronate is effective across age groups and bone density ranges. Evidence supports use both preventively in women in their 50s and therapeutically in women ≥65, including those who are osteopenic. Dosing frequency should follow study protocols (e.g., every 18 months in older women; every 5–10 years in preventive regimens).Vitamin D has a role in those at risk of deficiency. Particularly useful for people in rest homes, those with dark skin, or those living in low-sunlight regions (e.g., South Island).Avoid calcium supplements—prioritise dietary sources. Supplements offer minimal benefit for bone density or fracture prevention and carry risks (kidney stones, constipation, potential cardiovascular effects). A balanced diet that maintains a healthy BMI (>20) is preferred.Resources:Reid, Ian R, and Michael R McClung. “Osteopenia: A Key Target for Fracture Prevention.” The lancet. Diabetes & endocrinology 12.11 (2024): 856–864. Web. Reid, Ian R, and Michael R McClung. “Osteopenia: A Key Target for Fracture Prevention.” The lancet. Diabetes & endocrinology 12.11 (2024): 856–864. Web. Bolland, Mark J et al. “Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age.” The New England journal of medicine 392.3 (2025): 239–248. Web. https://osteoporosis.org.nz/wp-content/uploads/2024/09/ONZ-2017-Guidance-for-New-Zealand.pdfEmail me:[email protected] here:Apple: https://podcasts.apple.com/us/podcast/the-specialist-gp/id1845748299Spotify: https://open.spotify.com/show/3485r5V7iF251QH9dpnC1i?si=qQ2CUMa-SRSWMfha2HRjXA

Episode Overview: In this episode, we explore the realities of sexting and porn exposure among young people — what’s normal, what’s harmful, and how clinicians can respond with empathy and insight. To help unpack this, Dr Louise Kuegler is joined by Dr Claire Meehan, Senior Lecturer in Criminology at the University of Auckland. Through a real case, we discuss what happens when intimate images are shared without consent, and how to guide conversations that move beyond shame and fear toward trust, consent, and safety. In this episode we cover: • How common sexting is among teenagers, and why many view it as normal or positive • What happens when images are shared without consent — and how to respond clinically • The role of gender, double standards, and victim-blaming • How pornography shapes expectations and behaviour • What parents, teachers, and clinicians can do to help young people navigate digital consent Practical Clinical Pearls: • Normalise the conversation — sexting and porn exposure are common; avoid shame. • Reframe risk, don’t moralise — talk about consent, trust, and relationships rather than “don’t do it.” • Encourage rapid disclosure — reassure teens they won’t be punished for speaking up. • Address gender and power — challenge double standards and affirm that harm lies in the breach of consent. • Promote healthy alternatives — guide young people toward credible, age-appropriate sexual health education. Dr Claire Meehan is a Senior Lecturer in Criminology in the Faculty of Arts at the University of Auckland. Her research focuses on how young people navigate digital technology, sexuality, and consent — including their understandings of pornography and the sharing of intimate images. She holds a PhD in Criminology from the University of Ulster and postgraduate degrees from Queen’s University Belfast. Claire is the author of The Politics of Porn for Young People in New Zealand and the forthcoming Young People and Sexual Consent in the Digital Age. Resources: Meehan C. ‘They’re Much Too Young’: The Entanglement of Porn, Pleasure and Age in Sex Education. J Sex Res. 2025 Jul;62(6):1028-36. Meehan C. Talking with Girls about Porn. In: Mazzarella SR, editor. The Routledge Companion to Girls’ Studies. Abingdon: Taylor & Francis; 2024. p. 375-86. Meehan C, Wicks E. Consent Isn’t Just a Girl’s Thing: Gender, Consent and Image Based Sexual Abuse. In: James-Hawkins L, Ryan-Flood R, editors. Consent: Gender, Power and Subjectivity. Milton (or London) : Taylor & Francis; 2023 Nov. p. 197-209. https://netsafe.org.nz/ Netsafe NZ, helping NZ to be safe online https://stopncii.org/ Stop Non- consensual intimate image abuse. StopNCII.org introduces innovative technology that is used by tech and industry companies to protect people from the sharing of their intimate images online. https://takeitdown.ncmec.org/ This service is one step you can take to help remove online nude, partially nude, or sexually explicit photos and videos taken before you were 18.